Short Interest in Arcadia Biosciences, Inc. (NASDAQ:RKDA) Rises By 2,437.2%

Arcadia Biosciences, Inc. (NASDAQ:RKDAGet Free Report) saw a large growth in short interest during the month of August. As of August 14th, there was short interest totaling 88,674 shares, a growth of 2,437.2% from the July 30th total of 3,495 shares. Based on an average trading volume of 307,856 shares, the short-interest ratio is presently 0.3 days. Approximately 3.9% of the shares of the stock are sold short.

Arcadia Biosciences Stock Up 2.0%

Shares of Arcadia Biosciences stock traded up $0.01 during midday trading on Tuesday, hitting $0.49. The company’s stock had a trading volume of 56,755 shares, compared to its average volume of 238,036. The firm has a market capitalization of $1.18 million, a P/E ratio of -0.11 and a beta of 0.56. The stock has a 50-day simple moving average of $0.65 and a 200-day simple moving average of $1.12. Arcadia Biosciences has a 1-year low of $0.38 and a 1-year high of $6.71.

Arcadia Biosciences (NASDAQ:RKDAGet Free Report) last issued its quarterly earnings results on Thursday, August 13th. The basic materials company reported ($2.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.56) by ($1.53). The business had revenue of $1.44 million for the quarter, compared to analysts’ expectations of $1.90 million. Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 183.50%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings lowered Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, June 25th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

Read Our Latest Research Report on RKDA

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.

Featured Stories

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.